Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice

Reitz R. Flora Ilustrada Catarinense – Rosáceas. Itajaí: Santa Catarina; 1996. Kauffmann, 2004, Constituents from leaves of Quillaja brasiliensis, Nat Prod Res, 18, 153, 10.1080/14786410310001608055 Kensil, 1991, Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex, J Immunol, 146, 431, 10.4049/jimmunol.146.2.431 Barr, 1998, ISCOMs and other saponin based adjuvants, Adv Drug Deliv Rev, 32, 247, 10.1016/S0169-409X(98)00013-1 Fonseca, 2001, Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis, Vaccine, 19, 122, 10.1016/S0264-410X(00)00102-X Chapman, 2000, Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin+QS-21 vaccine: a dose–response study, Clin Cancer Res, 6, 874 Moreno, 2000, Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice, Vaccine, 18, 89, 10.1016/S0264-410X(99)00184-X Stittelaar, 2000, In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified QuilA components, Vaccine, 18, 2482, 10.1016/S0264-410X(00)00026-8 Evans, 2001, QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans, Vaccine, 19, 2080, 10.1016/S0264-410X(00)00415-1 de Sousa, 2004, Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins, Vaccine, 22, 2470, 10.1016/j.vaccine.2004.01.072 Hu, 2005, The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP™703, FEMS Immun Med Microbiol, 43, 269, 10.1016/j.femsim.2004.08.010 Meraldi, 2005, A strong CD8+ T cell response is elicited using the synthetic polypetide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites, Vaccine, 23, 2801, 10.1016/j.vaccine.2004.10.044 Higuchi, 1988, An acylated triterpenoid saponin from Quillaja saponaria, Phytochemistry, 27, 1165, 10.1016/0031-9422(88)80295-4 Soltysik, 1995, Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function, Vaccine, 13, 1403, 10.1016/0264-410X(95)00077-E Nord, 1999, Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina, Carbohydr Res, 320, 70, 10.1016/S0008-6215(99)00134-2 Nord, 2000, Novel acetylated triterpenoid saponin in a chromatographic fraction from Quillaja saponaria Molina, Carbohydr Res, 329, 817, 10.1016/S0008-6215(00)00248-2 San Martín, 1999, Industrial uses and sustainable supply of Quillaja saponaria (Rosaceae) saponins, Econ Bot, 53, 302, 10.1007/BF02866642 Silva, 2006, Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge, Vaccine, 24, 3313, 10.1016/j.vaccine.2006.01.024 Franco, 2002, Construction and characterization of a glycoprotein E deletion mutant of bovine herpesvirus type 1.2 strain isolated in Brazil, Braz J Microb, 33, 274, 10.1590/S1517-83822002000300018 Franco, 2002, A Brazilian glycoprotein E-negative bovine herpesvirus type 1.2a (BoHV-1.2a) mutant is attenuated for cattle and induces protection against wild-type virus challenge, Pesq Vet Bras, 22, 135, 10.1590/S0100-736X2002000400002